Purchase Order HHSN275201700455P
Award Date 6/16/17
Potential Completion Date 6/22/18
Potential Value $79K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The contract has a ceiling value of $100,502.64 and a completion date of September 2, 2020. Illumina has provided various sequencing systems, reagents, consumables, and bioinformatics products to support genomic research and diagnostics for NIDDK...
- This is a firm fixed price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The contract, valued at $80,449.94, is for the provision of Illumina's sequencing and analytical instruments and reagents to support NIDDK's genomic research and diagnostics efforts. The contract has no set-aside designation. Illumina has previously been awarded prime...
- This is a firm fixed price delivery order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $97,054.04 contract does not have a set-aside designation. Based on Illumina's history of supporting genomic research and diagnostics across federal agencies, this award is likely for the provision of Illumina's sequencing systems, consumables, and...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS), to Illumina, Inc. The contract, valued at $72,422.58, is for the provision of Illumina's sequencing instruments, reagents, and related products and services to support NIDDK's genomic research and analysis needs. Illumina has previously served as a prime contractor and...
- This is a federal purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Illumina, Inc. for the relocation of instruments. The firm fixed price contract has a ceiling value of $12,061.94 and a completion date of December 31, 2019. No set-aside designation was used. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has previously received prime contracts and sub-awards from agencies...
- This firm fixed price purchase order was awarded to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency. The $21,000.00 contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Illumina has previously supported genomic sequencing and analysis work across various federal agencies, including NIH, CDC, USDA, and VA,...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $9,500.00 contract provides Illumina's sequencing systems, reagents, and services to support genomic sequencing and analysis needs across various federal agencies....
- This is a $5,216.64 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. for the provision of sequencing systems, reagents, and related services. The award has no set-aside designation. Illumina, a for-profit manufacturer, has previously supported genomic sequencing and analysis efforts across various federal agencies including the NIH, CDC, USDA,...
- This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for maintenance support services on NIDA's existing Illumina sequencing systems. The contract has a ceiling value of $144,898.72 and an ultimate completion date of December 4, 2017. This purchase order is not associated with a set-aside program. Illumina, a manufacturer of sequencing and analysis products, has...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed-price delivery order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomics analysis equipment. The $193,926.00 contract, which has a completion date of September 2, 2025, is for the provision of consumables to support NIDDK's research and diagnostic activities. Illumina has a history of federal contract...